Our findings indicate that LEF effectively prevents pigment loss in the vitiligo mouse model by blocking melanocyte destruction via the suppression of CD8+ T cell-mediated cytotoxic responses (Figure 1 and Figure 2). The gene discussed is CD8A; the disease is vitiligo.